Status:
COMPLETED
Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC
Lead Sponsor:
Federico II University
Conditions:
Macular Degeneration Choroidal Neovascularization
Eligibility:
All Genders
50-90 years
Brief Summary
To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.
Detailed Description
Exudative neovascular macular degeneration is the primarily an age-related retinal condition The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that a...
Eligibility Criteria
Inclusion
- age older than 50 years
- diagnosis of neovascular macular degeneration
- absence of previous retinal surgery and congenital eye diseases.
- absence of errors of refraction
- absence of lens opacities
- absence of low-quality OCT and OCTA images
Exclusion
- • age younger than 50 years
- previous retinal surgery and congenital eye diseases
- errors of refraction
- lens opacities
- low-quality OCT and OCTA images
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05969418
Start Date
July 1 2023
End Date
December 21 2023
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University
Naples, Italy, 80121